Endotyping Humoral and Cellular Cross-Immunoreactivity between Metamizole and Mites in Patients with Allergic Multimorbidity
Celso Eduardo Olivier *
Instituto Alergoimuno de Americana, São Paulo, Brazil.
Luciana Sacilotto Carvalho
Instituto Alergoimuno de Americana, São Paulo, Brazil and Pharmacy College, Faculty of Americana (FAM), São Paulo, Brazil.
Alessandra Vieira de Oliveira
Instituto Alergoimuno de Americana, São Paulo, Brazil and Biomedicine College, Faculty of Americana (FAM), São Paulo, Brazil.
Daiana Guedes Pinto
Instituto Alergoimuno de Americana, São Paulo, Brazil.
Ana Paula Monezzi Teixeira
Instituto Alergoimuno de Americana, São Paulo, Brazil.
Cibele Silva Miguel
Instituto Alergoimuno de Americana, São Paulo, Brazil.
Nicole Sartoreto Rocha
Instituto Alergoimuno de Americana, São Paulo, Brazil.
Jhéssica Letícia Santos Santana
Instituto de Ensino e Pesquisa do Hospital de Amor de Barretos, São Paulo, Brazil.
Regiane Patussi Santos Lima
Mastellini Laboratories, São Paulo, Brazil.
Raquel Acácia Pereira Gonçalves Santos
Instituto Alergoimuno de Americana, São Paulo, Brazil.
Everton Salgado Monteiro
Department of Allergy and Immunopathology, Faculty of Medicine, São Paulo University, Brazil and BioAllergy Laboratories, Álvaro de Carvalho, São Paulo, Brazil.
*Author to whom correspondence should be addressed.
Abstract
Background: The association between non-steroidal anti-inflammatory drug (NSAID) hypersensitivity and allergic and inflammatory reactions elicited by food or mite allergens raises intriguing hypotheses about leukotriene pathways that may contribute to acute and chronic inflammatory processes in allergic individuals.
Aim: This study hypothesises that the Leukocyte Adherence Inhibition Test (LAIT) and the Tube Titration of Precipitins (TTP) may differentiate between degrees of cellular and humoral immunoreactivity and verify a supposed correlation between metamizole and mite immunoreactivity among patients diagnosed with allergic multimorbidity who have experienced exacerbations of allergic symptoms after the use of metamizole.
Methods: This descriptive observational study retrospectively compiled the electronic medical records of two cohorts of patients with these conditions who underwent one of these procedures concurrently with metamizole and Dermatophagoides spp. extract in an outpatient clinic.
Results: Leukocyte Adherence Inhibition (LAI) for metamizole ranged from 0% to 98%. The mean was 49.5%, the median was 53.5%, and the standard deviation was 28.3%. LAI results for Dermatophagoides spp. ranged from 0% to 98%. The mean was 61.9%; the median was 66%; the standard deviation was 28.4%. Pearson correlation analysis showed no significant relationship between LAIT results performed with metamizole and Dermatophagoides spp extract; r (88) = 0.05; p-value = 0.64. The mean TTP for metamizole was estimated at 1:214; the median was 1:128; SD was estimated at 1:174; and the mode was 1:256 (appearing 24 times). The mean TTP for the mite extract was estimated at 1:254; the median was 1:192; the SD was 1:187; and the mode was 1:512 (appearing 31 times). Pearson correlation indicated no significant relationship between TTP results performed with metamizole and mite extract: r (96) = 0.038; p-value = 0.7.
Conclusion: These preliminary results suggest that the TTP and LAIT performed with metamizole solution and Dermatophagoides spp. extract may discriminate against various degrees of humoral and cellular immunoreactivity in these two cohorts of allergic patients. These data suggest that the supposed synergistic effect of these two agents in producing allergic symptoms, as described in the literature, may be mostly pharmacological rather than immunological.
Keywords: Metamizole, dipyrone, Dermatophagoides pteronyssinus, Dermatophagoides farinae, allergic multimorbidity, NSAID hypersensitivity, leukocyte adherence inhibition test, tube titration of precipitins, cellular immunoreactivity, humoral immunoreactivity